Latest filing published 12 Oct 2026 for GENOWAY, €30k. Read the official filing
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alexandre Fraichard is a declared insider of Genoway (chief executive), with filings sourced from AMF. The record holds 10 filings, for trades running from 3 November 2021 to 10 October 2026.
On the open market, the record shows 8 purchases worth €571k and 2 sales worth €91k. Taken together, the purchases exceed the sales by €480k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 4 purchases and no sales.
Half of the purchases are above €61k and half below. Scaled by market value, the purchases weigh a median 0.25% of market cap (sample: 4 purchases). The 8 purchases reviewed show no overlap with other insiders buying the same stock within a month. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +3.7%. This is a record of the past, not a forecast.
On 12 October 2026 came the latest disclosure, an open-market purchase for €30k in Genoway. Filings reach the AMF feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations